PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.92%
Net income growth under 50% of MRVL's 326.22%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.17%
Negative yoy D&A while MRVL is 20.53%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-700.00%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
10.29%
Less SBC growth vs. MRVL's 52.11%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
17.19%
Less working capital growth vs. MRVL's 90.64%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-94.12%
Both yoy AR lines negative, with MRVL at -259.53%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-96.23%
Both reduce yoy inventory, with MRVL at -146.80%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
115.38%
AP growth well above MRVL's 2.59%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
38.49%
Lower 'other working capital' growth vs. MRVL's 99.19%. David Dodd would see fewer unexpected short-term demands on cash.
131.25%
Some yoy increase while MRVL is negative at -68.19%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
15.35%
Operating cash flow growth below 50% of MRVL's 109.72%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-18.90%
Both yoy lines negative, with MRVL at -55.82%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-49.27%
Both yoy lines negative, with MRVL at -29.29%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
12.95%
We have some liquidation growth while MRVL is negative at -63.17%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-561.29%
We reduce yoy other investing while MRVL is 1.36%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-103.00%
Both yoy lines negative, with MRVL at -152.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-50.00%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-47.83%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-18.18%
We cut yoy buybacks while MRVL is 99.27%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.